SYF0c91d4255ace459e929797c6757cdad3Registry ID: 2024-519672-12-00|Not Yet RecruitingPhase 2
Deflazacort TREATment in LMNArelated
Azienda Ospedaliero Universitaria PisanaCTIS (EMA)
Loading search results
interventional
N/A
1 country
6
Evaluation of the effect of therapy with Deflazacort drops 0.9 mg/kg/day on clinical outcome and secretome in adult and pediatric patients with L-CMD.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 15, 2024
Actual (reported)Evaluation of the effects of treatment with Deflazacort drops (0.9mg/kg/day in relation to the change of clinical parameters at each treatment time and follow up (T0-T6-T12-T15-T18).
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Formulated product
DEFLAN 22,75 mg/ml gocce orali, sospensione
The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
ORAL DROPS, SUSPENSION
View registry recordThe registry names these ingredients. The formulation’s exact chemical form has not been confirmed.
DEFLAN 22,75 mg/ml gocce orali, sospensione
Named ingredient: deflazacort
View registry recordRegistry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Azienda Ospedaliera di Padova
Padova, 35128, Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, 56126, Italy
Azienda Unita Sanitaria Locale Di Bologna
Bologna, 40139, Italy
Clinical Trial Center
First Submitted
November 15, 2024
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Contact the study team to confirm eligibility.
IRCCS Istituto Giannina Gaslini
Genoa, 16147, Italy
Ospedale Pediatrico Bambino Gesu
Rome, 00165, Italy
IRCCS Foundation Istituto Neurologico Carlo Besta
Milan, 20133, Italy